NIP
KITE

Nicholas Investment Partners’s Kite Pharma, Inc. KITE Stock Holding History

Nicholas Investment Partners’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-27,100
Closed -$2.81M – 285
2017
Q2 		$2.81M Buy
27,100
+4,229
+18% +$345K 0.2% 175
2017
Q1 		$1.8M Buy
+22,871
New +$1.41M 0.13% 220
2016
Q4 		– Sell
-56,066
Closed -$3.13M – 370
2016
Q3 		$3.13M Buy
56,066
+19,169
+52% +$1.07M 0.21% 195
2016
Q2 		$1.84M Buy
36,897
+7,716
+26% +$379K 0.13% 263
2016
Q1 		$1.34M Buy
+29,181
New +$1.41M 0.1% 266
2015
Q4 		– Sell
-33,919
Closed -$1.89M – 346
2015
Q3 		$1.89M Buy
33,919
+2,565
+8% +$161K 0.14% 251
2015
Q2 		$1.91M Buy
+31,354
New +$1.79M 0.12% 266

Other funds holding KITE

CI
Cowen Inc New York $1.39B AUM 60.14% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
WCM
Wildcat Capital Management New York $106M AUM 0.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCSAM
Tyrus Capital S.A.M. Monaco $10.5M AUM 4.88% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Nicholas Investment Partners's KITE Position: Q3 2017 in Review

Nicholas Investment Partners sold out of Kite Pharma, Inc. (KITE) in Q3 2017, closing a stake of 27,100 shares — an estimated $2.81M sold.

Nicholas Investment Partners first reported a position in KITE in Q2 2015 and held it in 7 quarters. The position peaked at $3.13M in Q3 2016. 244 funds tracked by Wall St. Rank hold KITE as of Q3 2017.

  • Nicholas Investment Partners reported no remaining Kite Pharma, Inc. position as of Q3 2017 after selling out during the quarter.
  • Nicholas Investment Partners sold 27,100 Kite Pharma, Inc. shares in Q3 2017, an estimated $2.81M.
  • Nicholas Investment Partners first reported a position in Kite Pharma, Inc. in Q2 2015 and held it in 7 quarters.
  • Nicholas Investment Partners's Kite Pharma, Inc. position peaked at $3.13M in Q3 2016.
  • 244 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q3 2017.

Based on Nicholas Investment Partners's 13F filing for Q3 2017, filed 13 Nov 2017.